Gestational Diabetes Reduces Adenosine Transport in Human Placental Microvascular Endothelium, an Effect Reversed by Insulin
dc.contributor.author | Salomon, Carlos | |
dc.contributor.author | Westermeier, Francisco | |
dc.contributor.author | Puebla, Carlos | |
dc.contributor.author | Arroyo, Pablo | |
dc.contributor.author | Guzman Gutierrez, Enrique | |
dc.contributor.author | Pardo, Fabian | |
dc.contributor.author | Leiva, Andrea | |
dc.contributor.author | Casanello, Paola | |
dc.contributor.author | Sobrevia, Luis | |
dc.date.accessioned | 2024-01-10T13:13:21Z | |
dc.date.available | 2024-01-10T13:13:21Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Gestational diabetes mellitus (GDM) courses with increased fetal plasma adenosine concentration and reduced adenosine transport in placental macrovascular endothelium. Since insulin modulates human equilibrative nucleoside transporters (hENTs) expression/activity, we hypothesize that GDM will alter hENT2-mediated transport in human placental microvascular endothelium (hPMEC), and that insulin will restore GDM to a normal phenotype involving insulin receptors A (IR-A) and B (IR-B). GDM effect on hENTs expression and transport activity, and IR-A/IR-B expression and associated cell signalling cascades (p42/44 mitogen-activated protein kinases (p42/44(mapk)) and Akt) role in hPMEC primary cultures was assayed. GDM associates with elevated umbilical whole and vein, but not arteries blood adenosine, and reduced hENTs adenosine transport and expression. IR-A/IR-B mRNA expression and p42/44(mapk)/Akt ratios ('metabolic phenotype') were lower in GDM. Insulin reversed GDM-reduced hENT2 expression/activity, IR-A/IR-B mRNA expression and p42/44(mapk)/Akt ratios to normal pregnancies ('mitogenic phenotype'). It is suggested that insulin effects required IR-A and IR-B expression leading to differential modulation of signalling pathways restoring GDM-metabolic to a normal-mitogenic like phenotype. Insulin could be acting as protecting factor for placental microvascular endothelial dysfunction in GDM. | |
dc.description.funder | Fondo Nacional de Desarrollo Cientifico y Tecnologico | |
dc.description.funder | Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) | |
dc.description.funder | Pontificia Universidad Catolica de Chile (PUC), Chile | |
dc.description.funder | CONICYT-PhD (Chile) fellowships | |
dc.description.funder | PUC-PhD fellowship | |
dc.format.extent | 14 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1371/journal.pone.0040578 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.pubmedid | MEDLINE:22808198 | |
dc.identifier.uri | https://doi.org/10.1371/journal.pone.0040578 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/78295 | |
dc.identifier.wosid | WOS:000306366400038 | |
dc.information.autoruc | Medicina;Arroyo P;S/I;121667 | |
dc.information.autoruc | Medicina;Casanello P;S/I;146772 | |
dc.information.autoruc | Ciencias Biológicas;Guzman E;S/I;197588 | |
dc.information.autoruc | Medicina;Leiva A;S/I;3362 | |
dc.information.autoruc | Medicina;Pardo F;S/I;1004392 | |
dc.information.autoruc | Ciencias Biológicas;Puebla C;S/I;124965 | |
dc.information.autoruc | Medicina;Salomon C;S/I;189546 | |
dc.information.autoruc | Medicina;Sobrevia L;S/I;1002656 | |
dc.information.autoruc | Ciencias Biológicas;Westermeier F;S/I;181374 | |
dc.issue.numero | 7 | |
dc.language.iso | en | |
dc.nota.acceso | Sin adjunto | |
dc.publisher | PUBLIC LIBRARY SCIENCE | |
dc.revista | PLOS ONE | |
dc.rights | registro bibliográfico | |
dc.subject | RECEPTOR ISOFORMS | |
dc.subject | GLUCOSE | |
dc.subject | RESISTANCE | |
dc.subject | MELLITUS | |
dc.subject | DYSFUNCTION | |
dc.subject | EXPRESSION | |
dc.subject | PROTEIN-1 | |
dc.subject | CELLS | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.ods | 05 Gender Equality | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.subject.odspa | 05 Igualdad de género | |
dc.title | Gestational Diabetes Reduces Adenosine Transport in Human Placental Microvascular Endothelium, an Effect Reversed by Insulin | |
dc.type | artículo | |
dc.volumen | 7 | |
sipa.codpersvinculados | 121667 | |
sipa.codpersvinculados | 146772 | |
sipa.codpersvinculados | 197588 | |
sipa.codpersvinculados | 3362 | |
sipa.codpersvinculados | 1004392 | |
sipa.codpersvinculados | 124965 | |
sipa.codpersvinculados | 189546 | |
sipa.codpersvinculados | 1002656 | |
sipa.codpersvinculados | 181374 | |
sipa.index | WOS | |
sipa.index | Scopus | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- file (10).pdf
- Size:
- 653.75 KB
- Format:
- Adobe Portable Document Format
- Description: